<DOC>
	<DOC>NCT01937754</DOC>
	<brief_summary>Oral supplementation of Neo40(TM), a nitrate lozenge, will reduce blood pressure in healthy adults with clinical prehypertension.</brief_summary>
	<brief_title>Study of the Effects of an Oral Nitric Oxide Supplement on Blood Pressure in Prehypertensive Adults</brief_title>
	<detailed_description />
	<mesh_term>Prehypertension</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Adults between the ages of 18 to 80 years Two blood pressure readings of &gt;/=135/80 mmHg at rest, thus representing prehypertension Informed consent Existence of any significant internal or cardiovascular disease; Current use of any antihypertensive medication. Inability to give informed consent, or fill out standard questionnaires or inability to follow up clinically.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Prehypertension</keyword>
	<keyword>Nitric Oxide</keyword>
	<keyword>Blood Pressure</keyword>
	<keyword>Functional Capacity</keyword>
	<keyword>Quality of Life</keyword>
</DOC>